BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23332094)

  • 1. Tropomyosin receptor kinases B and C are tumor progressive and metastatic marker in colorectal carcinoma.
    Sasahira T; Ueda N; Kurihara M; Matsushima S; Ohmori H; Fujii K; Bhawal UK; Yamamoto K; Kirita T; Kuniyasu H
    Hum Pathol; 2013 Jun; 44(6):1098-106. PubMed ID: 23332094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations among neural cell adhesion molecule, nerve growth factor, and its receptors, TrkA, TrkB, TrkC, and p75, in perineural invasion by basal cell and cutaneous squamous cell carcinomas.
    Chen-Tsai CP; Colome-Grimmer M; Wagner RF
    Dermatol Surg; 2004 Jul; 30(7):1009-16. PubMed ID: 15209791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotrophin receptor expression in human primary retinoblastomas and retinoblastoma cell lines.
    Stephan H; Zakrzewski JL; Bölöni R; Grasemann C; Lohmann DR; Eggert A
    Pediatr Blood Cancer; 2008 Feb; 50(2):218-22. PubMed ID: 17973327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of RhoGDI2 correlates with tumor progression and poor prognosis in colorectal carcinoma.
    Li X; Wang J; Zhang X; Zeng Y; Liang L; Ding Y
    Ann Surg Oncol; 2012 Jan; 19(1):145-53. PubMed ID: 21861235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
    Hu WG; Li JW; Feng B; Beveridge M; Yue F; Lu AG; Ma JJ; Wang ML; Guo Y; Jin XL; Zheng MH
    Eur Surg Res; 2007; 39(4):229-38. PubMed ID: 17446709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain-derived neurotrophic factor (BDNF)-induced tropomyosin-related kinase B (Trk B) signaling is a potential therapeutic target for peritoneal carcinomatosis arising from colorectal cancer.
    Tanaka K; Okugawa Y; Toiyama Y; Inoue Y; Saigusa S; Kawamura M; Araki T; Uchida K; Mohri Y; Kusunoki M
    PLoS One; 2014; 9(5):e96410. PubMed ID: 24801982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer.
    Karamitopoulou E; Zlobec I; Panayiotides I; Patsouris ES; Peros G; Rallis G; Lapas C; Karakitsos P; Terracciano LM; Lugli A
    Hum Pathol; 2011 Dec; 42(12):1888-96. PubMed ID: 21664646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.
    Lu Y; Jingyan G; Baorong S; Peng J; Xu Y; Cai S
    Cancer Biomark; 2012; 11(5):219-26. PubMed ID: 23220854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tropomyosin-related kinase B promotes distant metastasis of colorectal cancer through protein kinase B-mediated anoikis suppression and correlates with poor prognosis.
    Fan M; Sun J; Wang W; Fan J; Wang L; Zhang X; Yang A; Wang W; Zhang R; Li J
    Apoptosis; 2014 May; 19(5):860-70. PubMed ID: 24549576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of tropomysin-related kinase B in metastatic human pancreatic cancer cells.
    Sclabas GM; Fujioka S; Schmidt C; Li Z; Frederick WA; Yang W; Yokoi K; Evans DB; Abbruzzese JL; Hess KR; Zhang W; Fidler IJ; Chiao PJ
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):440-9. PubMed ID: 15701826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of trkB and trkC receptors and their ligands brain-derived neurotrophic factor and neurotrophin-3 in the murine amygdala.
    Krause S; Schindowski K; Zechel S; von Bohlen und Halbach O
    J Neurosci Res; 2008 Feb; 86(2):411-21. PubMed ID: 17828769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trks are novel oncogenes involved in the induction of neovascularization, tumor progression, and nodal metastasis in oral squamous cell carcinoma.
    Sasahira T; Ueda N; Yamamoto K; Bhawal UK; Kurihara M; Kirita T; Kuniyasu H
    Clin Exp Metastasis; 2013 Feb; 30(2):165-76. PubMed ID: 22886570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of risk of liver metastasis in colorectal adenocarcinoma based on the combination of risk factors including CD10 expression: multivariate analysis of clinicopathological and immunohistochemical factors.
    Ohji Y; Yao T; Eguchi T; Yamada T; Hirahashi M; Iida M; Tsuneyoshi M
    Oncol Rep; 2007 Mar; 17(3):525-30. PubMed ID: 17273728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of BDNF, TrkB, and p53 in early-stage squamous cell carcinoma of the uterine cervix.
    Moon A; Won KY; Lee JY; Kang I; Lee SK; Lee J
    Pathology; 2011 Aug; 43(5):453-8. PubMed ID: 21670725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of tropomyosin-related kinases A, B, and C in gastric cancer.
    Kamiya A; Inokuchi M; Otsuki S; Sugita H; Kato K; Uetake H; Sugihara K; Takagi Y; Kojima K
    Clin Transl Oncol; 2016 Jun; 18(6):599-607. PubMed ID: 26459250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TrkC promotes colorectal cancer growth and metastasis.
    Kim MS; Suh KW; Hong S; Jin W
    Oncotarget; 2017 Jun; 8(25):41319-41333. PubMed ID: 28455963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotrophic receptor, tropomyosin-related kinase B as an independent prognostic marker in gastric cancer patients.
    Tanaka K; Mohri Y; Nishioka J; Kobayashi M; Ohi M; Miki C; Tonouchi H; Nobori T; Kusunoki M
    J Surg Oncol; 2009 Apr; 99(5):307-10. PubMed ID: 19170129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.
    Gray MJ; Van Buren G; Dallas NA; Xia L; Wang X; Yang AD; Somcio RJ; Lin YG; Lim S; Fan F; Mangala LS; Arumugam T; Logsdon CD; Lopez-Berestein G; Sood AK; Ellis LM
    J Natl Cancer Inst; 2008 Jan; 100(2):109-20. PubMed ID: 18182619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p75 and TrkC neurotrophin receptors demonstrate a different immunoreactivity profile in comparison to TrkA and TrkB receptors in human normal pituitary gland and adenomas.
    Assimakopoulou M; Zolota V; Chondrogianni C; Gatzounis G; Varakis J
    Neuroendocrinology; 2008; 88(2):127-34. PubMed ID: 18319596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.